Aligos Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$7.32

+0.83 (+12.79%)

As of Feb 8, 2:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target -15.4% upside

Low Target $4.22

Average Target $6.19

High Target $8.57

Current Price $7.32

Current
$7.32

Target
$6.19

$4.22 $6.19 avg $8.57

Scenario Analysis

Bear Case

$4.22

-42.3%

Low target

Base Case

$6.19

-15.4%

Avg target

Bull Case

$8.57

+17.1%

High target

Risk/Reward

0.4x

Unfavorable

Price in Context

52-Week High

$7.62

-3.9% from high

52-Week Low

$3.04

+140.8% from low

Target vs 52W High

$6.19

-18.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%